In AML, the malignant cells are themselves immune-derived, and heightened activity in immune-related pathways—such as T cell receptor signaling or JAK-STAT signaling—may reflect increased leukemic cell activity or aggressiveness. The gene discussed is SOAT1; the disease is acute myeloid leukemia.